Home Page

Researchers from the Warren Center for Neuroscience Drug Discovery, in collaboration with Boehringer Ingelheim, developed a compound that can treat both negative and positive symptoms of schizophrenia in rodents. The compound holds promise as an investigational tool and an inspiration for novel schizophrenia therapies. Read More

The Center for Computational and Systems Biology, launching at Vanderbilt University in early 2025, will focus on analyzing vast amounts of data to look for new ways to tackle human diseases and conditions. Read More

For her studies related to the molecular and cellular mechanisms of touch circuit development, Shan Meltzer received a prestigious honor from the American Association for Anatomy. Read More

In December, Tennessee Bureau of Investigation Director David Rausch and senior officials visited Vanderbilt’s Warren Center for Neuroscience Drug Discovery to learn more about how cutting-edge research is combatting the opioid crisis. Read More

Meet Jo Ann Byl, senior research specialist in the School of Medicine Basic Sciences Department of Biochemistry. Read More

Congratulations to our School of Medicine Basic Sciences members who were promoted or received new appointments between October and December 2024. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school.  Read More

A leading chemical biologist working on ribosomally synthesized and post-translationally modified peptides, Doug Mitchell has joined the School of Medicine Basic Sciences as the William Kelly Warren Sr. Professor of Biochemistry and director of the Vanderbilt Institute for Chemical Biology. He also has been named professor of chemistry. Read More

As 2024 comes to a close, we take a look back at the accomplishments and contributions to science and society made by School of Medicine Basic Sciences community members throughout the past year. The efforts of our faculty, trainees, staff, and collaborators have resulted pioneering discoveries that tangibly benefit society. Read More

Lori Rudolph-Owen, an accomplished figure in the biotechnology industry and a Vanderbilt University School of Medicine Basic Sciences alum, shared her insights on career progression and drug development on Oct. 3 as part of BRET’s Ph.D. Career Stories, a series focused on various alums and their professions. Read More

Doug Kojetin, associate professor of biochemistry, and a collaborator from the Guangzhou Laboratory, use NMR and crystallography to elucidate the binding pose of GW9662 and T0070907 cobound with synthetic ligands for the first time. Read More